These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 32839275)

  • 1. Mind the methods of determining minimal important differences: three critical issues to consider.
    Devji T; Carrasco-Labra A; Guyatt G
    Evid Based Ment Health; 2021 May; 24(2):77-81. PubMed ID: 32839275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serious reporting deficiencies exist in minimal important difference studies: current state and suggestions for improvement.
    Carrasco-Labra A; Devji T; Qasim A; Phillips M; Johnston BC; Devasenapathy N; Zeraatkar D; Bhatt M; Jin X; Brignardello-Petersen R; Urquhart O; Foroutan F; Schandelmaier S; Pardo-Hernandez H; Vernooij RW; Huang H; Rizwan Y; Siemieniuk R; Lytvyn L; Patrick DL; Ebrahim S; Furukawa TA; Nesrallah G; Schunemann HJ; Bhandari M; Thabane L; Guyatt GH
    J Clin Epidemiol; 2022 Oct; 150():25-32. PubMed ID: 35760237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Minimal important differences for improvement in shoulder condition patient-reported outcomes: a systematic review to inform a
    Hao Q; Devji T; Zeraatkar D; Wang Y; Qasim A; Siemieniuk RAC; Vandvik PO; Lähdeoja T; Carrasco-Labra A; Agoritsas T; Guyatt G
    BMJ Open; 2019 Feb; 9(2):e028777. PubMed ID: 30787096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Minimal important difference estimates for patient-reported outcomes: A systematic survey.
    Carrasco-Labra A; Devji T; Qasim A; Phillips MR; Wang Y; Johnston BC; Devasenapathy N; Zeraatkar D; Bhatt M; Jin X; Brignardello-Petersen R; Urquhart O; Foroutan F; Schandelmaier S; Pardo-Hernandez H; Hao Q; Wong V; Ye Z; Yao L; Vernooij RWM; Huang H; Zeng L; Rizwan Y; Siemieniuk R; Lytvyn L; Patrick DL; Ebrahim S; Furukawa TA; Nesrallah G; Schünemann HJ; Bhandari M; Thabane L; Guyatt GH
    J Clin Epidemiol; 2021 May; 133():61-71. PubMed ID: 33321175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A systematic survey identified methodological issues in studies estimating anchor-based minimal important differences in patient-reported outcomes.
    Wang Y; Devji T; Qasim A; Hao Q; Wong V; Bhatt M; Prasad M; Wang Y; Noori A; Xiao Y; Ghadimi M; Lozano LEC; Phillips MR; Carrasco-Labra A; King M; Terluin B; Terwee CB; Walsh M; Furukawa TA; Guyatt GH
    J Clin Epidemiol; 2022 Feb; 142():144-151. PubMed ID: 34752937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Minimal important differences for fatigue patient reported outcome measures-a systematic review.
    Nordin Å; Taft C; Lundgren-Nilsson Å; Dencker A
    BMC Med Res Methodol; 2016 May; 16():62. PubMed ID: 27387456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Minimally important difference estimates and methods: a protocol.
    Johnston BC; Ebrahim S; Carrasco-Labra A; Furukawa TA; Patrick DL; Crawford MW; Hemmelgarn BR; Schunemann HJ; Guyatt GH; Nesrallah G
    BMJ Open; 2015 Oct; 5(10):e007953. PubMed ID: 26428330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Credibility and Generalization of the Minimally Important Difference Concept in Dermatology: A Scoping Review.
    Speeckaert R; Belpaire A; Herbelet S; Lambert J; van Geel N
    JAMA Dermatol; 2022 Nov; 158(11):1304-1314. PubMed ID: 36044227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patient-Reported Outcome Measure Use in Guidelines Published by the American Academy of Ophthalmology: A Review.
    Yu CW; Nanji K; Hatamnejad A; Gemae M; Joarder I; Achunair A; Devji T; Phillips M; Zeraatkar D; Steel DH; Guymer RH; Sivaprasad S; Wykoff CC; Chaudhary V
    Ophthalmology; 2023 Nov; 130(11):1201-1211. PubMed ID: 37429499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluating the credibility of anchor based estimates of minimal important differences for patient reported outcomes: instrument development and reliability study.
    Devji T; Carrasco-Labra A; Qasim A; Phillips M; Johnston BC; Devasenapathy N; Zeraatkar D; Bhatt M; Jin X; Brignardello-Petersen R; Urquhart O; Foroutan F; Schandelmaier S; Pardo-Hernandez H; Vernooij RW; Huang H; Rizwan Y; Siemieniuk R; Lytvyn L; Patrick DL; Ebrahim S; Furukawa T; Nesrallah G; Schünemann HJ; Bhandari M; Thabane L; Guyatt GH
    BMJ; 2020 Jun; 369():m1714. PubMed ID: 32499297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application of minimal important differences in degenerative knee disease outcomes: a systematic review and case study to inform
    Devji T; Guyatt GH; Lytvyn L; Brignardello-Petersen R; Foroutan F; Sadeghirad B; Buchbinder R; Poolman RW; Harris IA; Carrasco-Labra A; Siemieniuk RAC; Vandvik PO
    BMJ Open; 2017 May; 7(5):e015587. PubMed ID: 28495818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Minimally Important Differences in Patient or Proxy-Reported Outcome Studies Relevant to Children: A Systematic Review.
    Ebrahim S; Vercammen K; Sivanand A; Guyatt GH; Carrasco-Labra A; Fernandes RM; Crawford MW; Nesrallah G; Johnston BC
    Pediatrics; 2017 Mar; 139(3):. PubMed ID: 28196931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patient-Reported Outcome Measures in Chemotherapy-Induced Peripheral Neurotoxicity: Defining Minimal and Clinically Important Changes.
    Li T; Timmins HC; Trinh T; Mizrahi D; Harrison M; Horvath LG; Grimison P; Friedlander M; Kiernan MC; King MT; Rutherford C; Goldstein D; Park SB
    J Natl Compr Canc Netw; 2023 Feb; 21(2):125-132.e3. PubMed ID: 36791763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An extension minimal important difference credibility item addressing construct proximity is a reliable alternative to the correlation item.
    Wang Y; Devji T; Carrasco-Labra A; Qasim A; Hao Q; Kum E; Devasenapathy N; King MT; Terluin B; Terwee CB; Walsh M; Furukawa TA; Tsujimoto Y; Guyatt GH
    J Clin Epidemiol; 2023 May; 157():46-52. PubMed ID: 36878330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identifying the minimal important difference in patient-reported outcome measures in the field of people with severe mental illness: a pre-post-analysis of the Illness Management and Recovery Programme.
    Beentjes TAA; Teerenstra S; Vermeulen H; Goossens PJJ; der Sanden MWGN; van Gaal BGI
    Qual Life Res; 2021 Jun; 30(6):1723-1733. PubMed ID: 33594528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psychometric properties of patient-reported outcome measures for dysphagia in head and neck cancer: a systematic review protocol using COSMIN methodology.
    Manduchi B; Che Z; Fitch MI; Ringash J; Howell D; Martino R
    Syst Rev; 2022 Feb; 11(1):27. PubMed ID: 35168687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estimating minimally important differences for the PROMIS pain interference scales: results from 3 randomized clinical trials.
    Chen CX; Kroenke K; Stump TE; Kean J; Carpenter JS; Krebs EE; Bair MJ; Damush TM; Monahan PO
    Pain; 2018 Apr; 159(4):775-782. PubMed ID: 29200181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. COSMIN guideline for systematic reviews of patient-reported outcome measures.
    Prinsen CAC; Mokkink LB; Bouter LM; Alonso J; Patrick DL; de Vet HCW; Terwee CB
    Qual Life Res; 2018 May; 27(5):1147-1157. PubMed ID: 29435801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.